logo
Why EVgo Stock Rocketed Over 30% Higher Today

Why EVgo Stock Rocketed Over 30% Higher Today

Yahoo06-05-2025

Key Points
EVgo is steadily growing its charging network.
Record revenue is moving it closer to achieving positive adjusted EBITDA.
A record quarter helped shares of EVgo (NASDAQ: EVGO) surge higher by more than 30% Tuesday morning. That spike came after revenue at the electric vehicle (EV) charger company came in 36% higher year over year.
Its first-quarter results also topped analyst expectations. After installing 180 new charging stalls, the company ended the first quarter with 4,240 operating EV stalls. Investors liked what they heard, sending shares higher by 35.7% as of 11:30 a.m. ET.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Image source: EVgo.
An uphill battle for EVgo
The company reported an adjusted operating loss of $5.9 million with revenue of $75.3 million. Wall Street analysts were expecting a $6.6 million loss on sales of $71.5 million, according to FactSet Research. Maybe more important for investors, though, was reaffirmed company guidance for up to $10 million in adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) this year. So far, that metric has never been in positive territory for the company.
"We anticipate being minimally impacted by tariffs, and we remain focused on achieving adjusted EBITDA breakeven in 2025 while investing in growth, including our next-generation charging experience," stated EVgo CEO Badar Khan.
The company is growing strongly despite increasing macro headwinds. EV sales growth rates have slowed in the United States. The Trump administration has also said it plans to end EV subsidies put in place during Joe Biden's term.
The stock's massive move in response to EVgo's quarterly results likely came due to its sharp drop in recent months. Even with today's jump, EVgo shares have been cut in half over the last six months.
The good news is that operating profit looks attainable despite the ongoing headwinds. If EV adoption does continue to grow, even more slowly, EVgo should reach operating profitability soon. That's enough for some investors to jump aboard today.
Should you invest $1,000 in EVgo right now?
Before you buy stock in EVgo, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and EVgo wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $611,589!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $697,613!*
Now, it's worth noting Stock Advisor's total average return is 894% — a market-crushing outperformance compared to 163% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma

Associated Press

time13 minutes ago

  • Associated Press

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Zenas To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired stock of Zenas pursuant and/or traceable to Zenas' registration statement for the initial public offering held on or about September 13, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - June 8, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Zenas BioPharma, Inc. ('Zenas' or the 'Company') (NASDAQ: ZBIO) and reminds investors of the June 16, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. [ This image cannot be displayed. Please visit the source: ] Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Zenas BioPharma materially overstated the amount of time it would be able to fund its operations using existing cash and expected net proceeds from the IPO; and (2) as a result, defendants' public statements were materially false and misleading at all relevant times and negligently prepared. When the true details entered the market, the lawsuit claims that investors suffered damages. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Zenas' conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Zenas BioPharma class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. To view the source version of this press release, please visit

This Week: Are Tariff Price Hikes Finally Here?
This Week: Are Tariff Price Hikes Finally Here?

Business of Fashion

time17 minutes ago

  • Business of Fashion

This Week: Are Tariff Price Hikes Finally Here?

What's Happening: On Wednesday, the US Bureau of Labor Statistics will release inflation data for May, the first inflation reading taken entirely after Trump's tariffs went into effect. In April, consumer prices rose 2.3 percent, just under the economists' consensus. Delayed Impact: Forecasters are calling for a mild uptick in prices, if that. Many fashion and beauty brands have announced price increases, often to be implemented on select products over the summer rather than right away. This gives consumers a bit of time to acclimate to their new, more expensive reality. And it builds in room to change course on the off chance Trump calls the whole trade war off in the meantime. Rock and a Hard Place: This strategic approach to price increases is savvy, but for many brands also borne out of a lack of options. After raising prices so much in the post-pandemic years, companies are worried they'll lose customers by hiking further, even if they have a good reason. Questioning Reality: Whether consumers believe prices are rising can have a big impact on inflation, so all those early warnings from brands may become a self-fulfilling prophecy even if Trump doesn't announce a single new tariff. There are also growing questions about the numbers themselves. Last week, economists raised questions in the financial press about whether inflation data could still be trusted, noting hiring freezes and layoffs had curtailed the government's ability to conduct its massive monthly survey of consumer prices. What to Expect at The Business of Beauty Global Forum 2025 What's Happening: On June 9 and 10, The Business of Beauty holds its third annual gathering in Napa Valley. A second class of entrepreneurs will also receive The Business of Beauty Global Awards. In the News: Speakers include Hailey Rhode Bieber, fresh off her $1 billion deal. Tracee Ellis Ross will share her observations on the needs of the Black and texturised hair community at a time when DEI is under siege. Global Perspective: Founders from international brands including Beauty of Joseon, Ultra Violette, Byoma and Nykaa will address challenges and opportunities in the global beauty market. Attorney Lindsay Toczylowski will speak on her efforts to help her client, Andry José Hernández Romero, the Venezuelan makeup artist currently detained in an El Salvador prison. See for Yourself: If you won't be in Napa Valley, catch these speakers and more on the livestream. The Week Ahead wants to hear from you! Send tips, suggestions, complaints and compliments to

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store